mirror of
https://github.com/K-Dense-AI/claude-scientific-skills.git
synced 2026-01-26 16:58:56 +08:00
- Updated SKILL.md in citation management to include best practices for identifying seminal and high-impact papers, emphasizing citation count thresholds, venue quality tiers, and author reputation indicators. - Expanded literature review SKILL.md to prioritize high-impact papers, detailing citation metrics, journal tiers, and author reputation assessment. - Added comprehensive evaluation strategies for paper impact and quality in literature_search_strategies.md, including citation count significance and journal impact factor guidance. - Improved research lookup scripts to prioritize results based on citation count, venue prestige, and author reputation, enhancing the quality of research outputs.
248 lines
8.7 KiB
Markdown
248 lines
8.7 KiB
Markdown
# Cell Press Summary, Highlights, and eTOC Examples
|
||
|
||
Examples of Cell Press-specific elements including Summary (abstract), Highlights, and eTOC blurb.
|
||
|
||
---
|
||
|
||
## Complete Example 1: Senescence and Aging
|
||
|
||
### Summary (150 words max)
|
||
|
||
```
|
||
Cellular senescence is a stress response that prevents damaged cell
|
||
proliferation but can drive tissue dysfunction through the senescence-
|
||
associated secretory phenotype (SASP). How senescent cells resist
|
||
apoptosis despite expressing pro-apoptotic p53 has remained unclear.
|
||
Here, we identify FOXO4 as a pivotal mediator of senescent cell viability.
|
||
FOXO4 is highly expressed in senescent cells and directly interacts with
|
||
p53, retaining it in the nucleus and preventing p53-mediated apoptosis.
|
||
A cell-permeable peptide that disrupts FOXO4-p53 interaction selectively
|
||
induces p53 nuclear exclusion and apoptosis in senescent cells without
|
||
affecting proliferating cells. In vivo, this FOXO4 peptide neutralizes
|
||
doxorubicin-induced senescent cells and restores fitness, fur density,
|
||
and renal function in naturally aged mice. These findings establish
|
||
FOXO4-mediated p53 sequestration as a senescence-specific survival
|
||
pathway and demonstrate the therapeutic potential of targeted senescent
|
||
cell elimination.
|
||
```
|
||
|
||
### Highlights (≤85 characters each)
|
||
|
||
```
|
||
• FOXO4 is selectively upregulated in senescent cells and binds p53
|
||
|
||
• FOXO4-p53 interaction retains p53 in the nucleus, preventing apoptosis
|
||
|
||
• A FOXO4-targeting peptide induces apoptosis specifically in senescent cells
|
||
|
||
• FOXO4 peptide treatment restores fitness and organ function in aged mice
|
||
```
|
||
|
||
### eTOC Blurb (30-50 words)
|
||
|
||
```
|
||
Baar et al. identify FOXO4 as a critical mediator of senescent cell survival
|
||
through p53 sequestration. A peptide disrupting FOXO4-p53 interaction
|
||
selectively eliminates senescent cells and restores tissue function in
|
||
aged mice, establishing proof-of-concept for targeted senolytic therapy.
|
||
```
|
||
|
||
### In Brief (1 sentence)
|
||
|
||
```
|
||
A FOXO4-targeting peptide selectively eliminates senescent cells by
|
||
releasing p53, restoring tissue function in aged mice.
|
||
```
|
||
|
||
---
|
||
|
||
## Complete Example 2: Genome Organization
|
||
|
||
### Summary (150 words max)
|
||
|
||
```
|
||
The three-dimensional organization of chromosomes within the nucleus
|
||
influences gene expression, DNA replication, and genome stability.
|
||
Phase separation has emerged as a potential mechanism for organizing
|
||
nuclear contents, but whether condensates can shape chromosome
|
||
structure in vivo remains unknown. Here, we show that the transcriptional
|
||
coactivator BRD4 forms liquid-like condensates at super-enhancers that
|
||
organize associated chromatin into hub structures. Optogenetic induction
|
||
of BRD4 condensates is sufficient to remodel chromosome topology and
|
||
activate transcription within minutes. Conversely, disruption of BRD4
|
||
condensates with the small molecule JQ1 dissolves chromatin hubs and
|
||
rapidly silences super-enhancer-controlled genes. Single-molecule
|
||
tracking reveals that condensate formation increases the local
|
||
concentration of transcription machinery 100-fold, explaining the
|
||
transcriptional potency of super-enhancers. These results establish
|
||
phase separation as a mechanism for chromatin organization and
|
||
transcriptional control with implications for understanding and
|
||
targeting oncogenic super-enhancers.
|
||
```
|
||
|
||
### Highlights
|
||
|
||
```
|
||
• BRD4 forms liquid condensates at super-enhancers in living cells
|
||
|
||
• BRD4 condensates organize chromatin into transcriptionally active hubs
|
||
|
||
• Optogenetic condensate induction rapidly remodels chromatin topology
|
||
|
||
• Condensates concentrate transcription machinery 100-fold locally
|
||
```
|
||
|
||
### eTOC Blurb
|
||
|
||
```
|
||
Sabari et al. demonstrate that BRD4 forms phase-separated condensates
|
||
at super-enhancers that organize chromatin into hub structures and
|
||
concentrate transcription machinery. Optogenetic manipulation reveals
|
||
that condensate formation directly drives chromatin remodeling and
|
||
transcriptional activation.
|
||
```
|
||
|
||
---
|
||
|
||
## Complete Example 3: Metabolism and Immunity
|
||
|
||
### Summary (150 words max)
|
||
|
||
```
|
||
Immune cells undergo dramatic metabolic reprogramming upon activation,
|
||
switching from oxidative phosphorylation to aerobic glycolysis. This
|
||
metabolic shift is thought to support the biosynthetic demands of
|
||
rapid proliferation, but whether specific metabolites directly regulate
|
||
immune cell function remains largely unexplored. Here, we show that
|
||
the glycolytic metabolite phosphoenolpyruvate (PEP) sustains T cell
|
||
receptor signaling by inhibiting sarco/endoplasmic reticulum Ca²⁺-ATPase
|
||
(SERCA) activity. PEP accumulates in activated T cells and directly
|
||
binds SERCA, preventing calcium reuptake and prolonging store-operated
|
||
calcium entry. Genetic or pharmacological enhancement of PEP levels
|
||
augments T cell effector function and anti-tumor immunity in vivo.
|
||
Conversely, tumor-derived lactate suppresses PEP levels and impairs
|
||
T cell calcium signaling, contributing to tumor immune evasion. These
|
||
findings reveal an unexpected signaling role for a glycolytic
|
||
intermediate and suggest metabolic strategies to enhance T cell
|
||
responses in cancer immunotherapy.
|
||
```
|
||
|
||
### Highlights
|
||
|
||
```
|
||
• Phosphoenolpyruvate (PEP) accumulates during T cell activation
|
||
|
||
• PEP directly binds and inhibits SERCA to sustain calcium signaling
|
||
|
||
• Enhancing PEP levels augments anti-tumor T cell immunity
|
||
|
||
• Tumor lactate suppresses T cell PEP levels and calcium signaling
|
||
```
|
||
|
||
### eTOC Blurb
|
||
|
||
```
|
||
Ho et al. discover that the glycolytic metabolite phosphoenolpyruvate
|
||
directly regulates T cell calcium signaling by inhibiting SERCA. This
|
||
metabolic-signaling link is exploited by tumors through lactate
|
||
secretion and offers new targets for cancer immunotherapy.
|
||
```
|
||
|
||
---
|
||
|
||
## Graphical Abstract Description Examples
|
||
|
||
### For Senescence Paper
|
||
|
||
```
|
||
"Graphical abstract for Cell paper on FOXO4 and senescence:
|
||
|
||
Left panel: Senescent cell (enlarged, irregular shape) with FOXO4 (blue
|
||
oval) binding p53 (green oval) in nucleus, preventing apoptosis. Label:
|
||
'FOXO4 sequesters p53 → Senescent cell survival'
|
||
|
||
Center panel: Same senescent cell with FOXO4 peptide (red wedge)
|
||
disrupting FOXO4-p53 interaction. p53 moves to mitochondria (orange
|
||
organelles). Label: 'FOXO4 peptide disrupts interaction'
|
||
|
||
Right panel: Senescent cell undergoing apoptosis (fragmenting). Label:
|
||
'Selective senescent cell death'
|
||
|
||
Bottom: Aged mouse (grey, hunched) → Treatment arrow → Rejuvenated mouse
|
||
(brown, active). Label: 'Restored fitness in aged mice'
|
||
|
||
Color scheme: Blue for FOXO4, green for p53, red for peptide, grey
|
||
background for cells."
|
||
```
|
||
|
||
### For Chromatin Paper
|
||
|
||
```
|
||
"Graphical abstract for Cell paper on BRD4 condensates:
|
||
|
||
Top row: Diagram showing BRD4 molecules (purple dots) clustering at
|
||
super-enhancer (yellow region on DNA strand), forming condensate
|
||
(purple droplet). Transcription factors (orange, green, blue small
|
||
circles) accumulate inside condensate.
|
||
|
||
Middle: Chromatin fibers (grey) being pulled into hub structure around
|
||
condensate. Arrow showing '100× local concentration increase'
|
||
|
||
Bottom: Two panels - Left shows 'JQ1' treatment dissolving condensate
|
||
and chromatin hub dispersing. Right shows 'Optogenetic activation'
|
||
creating new condensate with chromatin reorganization. Gene expression
|
||
indicators (up arrow, down arrow) for each condition."
|
||
```
|
||
|
||
---
|
||
|
||
## Writing Tips for Cell Elements
|
||
|
||
### Summary Tips
|
||
|
||
1. **First sentence**: Establish the biological context
|
||
2. **Second sentence**: State what was unknown (the gap)
|
||
3. **"Here, we show/identify/demonstrate"**: Clear transition to your work
|
||
4. **Middle sentences**: Key findings with mechanism
|
||
5. **Final sentence**: Significance and implications
|
||
|
||
### Highlights Tips
|
||
|
||
- **Start with a noun or verb**: "FOXO4 forms..." or "Activation of..."
|
||
- **One finding per bullet**: Don't combine multiple points
|
||
- **Be specific**: Include the protein/gene/pathway name
|
||
- **Check character count**: Strictly ≤85 characters including spaces
|
||
- **Cover different findings**: Don't repeat the same point
|
||
|
||
### eTOC Blurb Tips
|
||
|
||
- **Start with author names**: "Smith et al. show that..."
|
||
- **One or two sentences only**: Keep it punchy
|
||
- **Include the key mechanism**: Not just the finding
|
||
- **End with significance**: Why readers should care
|
||
|
||
---
|
||
|
||
## Character Counting for Highlights
|
||
|
||
Use this to check your highlights:
|
||
|
||
```
|
||
• This highlight is exactly 52 characters long including sp
|
||
↑ Count: 52 characters ✓ (under 85)
|
||
|
||
• This highlight is getting close to the maximum allowed character limit
|
||
↑ Count: 73 characters ✓ (under 85)
|
||
|
||
• This highlight demonstrates what happens when you try to include way too much info
|
||
↑ Count: 88 characters ✗ (over 85 - need to shorten)
|
||
```
|
||
|
||
---
|
||
|
||
## See Also
|
||
|
||
- `cell_press_style.md` - Comprehensive Cell Press writing guide
|
||
- `nature_abstract_examples.md` - Compare with Nature abstract style
|
||
|